These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 17522248
21. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR. Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474 [Abstract] [Full Text] [Related]
22. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers. Wang Z, Grasela DM, Krishna G. Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724 [Abstract] [Full Text] [Related]
23. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM. Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729 [Abstract] [Full Text] [Related]
25. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Murphy K, Noonan M, Silkoff PE, Uryniak T. Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718 [Abstract] [Full Text] [Related]
26. The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels. Bays HE, Maki KC, Doyle RT, Stein E. Postgrad Med; 2009 Sep; 121(5):145-50. PubMed ID: 19820283 [Abstract] [Full Text] [Related]
28. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R, Schreiber C. Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [Abstract] [Full Text] [Related]
30. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT. J Am Coll Cardiol; 2007 Aug 14; 50(7):600-6. PubMed ID: 17692744 [Abstract] [Full Text] [Related]
31. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics. Algorta J, Pena MA, Alvarez A, Maraschiello C, Maruhn D, Windisch M, Mucke HA. Int J Clin Pharmacol Ther; 2009 Jul 14; 47(7):483-90. PubMed ID: 19640356 [Abstract] [Full Text] [Related]
32. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, Murray GD. J Clin Oncol; 2006 Jul 20; 24(21):3401-7. PubMed ID: 16849754 [Abstract] [Full Text] [Related]
33. A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty. Viscusi ER, Gimbel JS, Halder AM, Snabes M, Brown MT, Verburg KM. Anesth Analg; 2008 Aug 20; 107(2):652-60. PubMed ID: 18633048 [Abstract] [Full Text] [Related]
35. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM, Messina J, Xie F, Hale M. Clin Ther; 2007 Apr 20; 29(4):588-601. PubMed ID: 17617282 [Abstract] [Full Text] [Related]
36. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study. Lim KS, Kim JR, Choi YJ, Shin KH, Kim KP, Hong JH, Cho JY, Shin HS, Yu KS, Shin SG, Kwon OH, Hwang DM, Kim JA, Jang IJ. Clin Ther; 2008 Oct 20; 30(10):1817-30. PubMed ID: 19014837 [Abstract] [Full Text] [Related]
37. Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension. Tzimos A, Samokhvalov V, Kramer M, Ford L, Gassmann-Mayer C, Lim P, Eerdekens M. Am J Geriatr Psychiatry; 2008 Jan 20; 16(1):31-43. PubMed ID: 18165460 [Abstract] [Full Text] [Related]
38. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine. Aurora SK, Rozen TD, Kori SH, Shrewsbury SB. Headache; 2009 Jun 20; 49(6):826-37. PubMed ID: 19545249 [Abstract] [Full Text] [Related]
39. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Kress HG, Orońska A, Kaczmarek Z, Kaasa S, Colberg T, Nolte T. Clin Ther; 2009 Jun 20; 31(6):1177-91. PubMed ID: 19695386 [Abstract] [Full Text] [Related]
40. Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control. Preuss HG, Garis RI, Bramble JD, Bagchi D, Bagchi M, Rao CV, Satyanarayana S. Int J Clin Pharmacol Res; 2005 Jun 20; 25(3):133-44. PubMed ID: 16366421 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]